Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

NCT01026792 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

NIH

Sponsor class

Conditions

Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Cervical Squamous Cell Carcinoma
Recurrent Cervical Carcinoma
Stage IIIA Cervical Cancer
Stage IIIB Cervical Cancer
Stage IVA Cervical Cancer
Stage IVB Cervical Cancer

Interventions

DRUG: Temsirolimus
OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)